WISP1 Antikörper (AA 130-251)
Kurzübersicht für WISP1 Antikörper (AA 130-251) (ABIN7175846)
Target
Alle WISP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 130-251
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human WNT1-inducible-signaling pathway protein 1 protein (130-251AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IF:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- WISP1 (WNT1 Inducible Signaling Pathway Protein 1 (WISP1))
-
Andere Bezeichnung
- WISP1
-
Hintergrund
-
Background: Downstream regulator in the Wnt/Frizzled-signaling pathway. Associated with cell survival. Attenuates p53-mediated apoptosis in response to DNA damage through activation of AKT kinase. Up-regulates the anti-apoptotic Bcl-X(L) protein. Adheres to skin and melanoma fibroblasts. In vitro binding to skin fibroblasts occurs through the proteoglycans, decorin and biglycan.
Aliases: CCN4 antibody, WISP1 antibody, CCN family member 4 antibody, WNT1-inducible-signaling pathway protein 1 antibody, WISP-1 antibody, Wnt-1-induced secreted protein antibody
-
UniProt
- O95388
-
Pathways
- WNT Signalweg, Growth Factor Binding
Target
-